Knightscope, a developer of security robots and blue light emergency communication systems, has announced a new contract for seven robots with a publicly traded biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases.
According to Knightscope, its new client has subscribed to one K5 Autonomous Security Robot (ASR) assigned to patrol a four-story garage and six K1-Tower ASRs that will watch over building entrances, open areas and parking lots throughout the corporate campus.
Knightscope highlights that a secure and resilient pharmaceutical supply chain in the US is the best means to ensure that patients and the healthcare system have access to a consistent and dependable supply of critical medicines.
At the top of the supply chain are the pharmaceutical corporate campuses that require a robust, multi-layered safety and security program.
Knightscope says that its security robot technologies will help safeguard the material and intellectual property under development at this cutting-edge facility as well as the staff who are assisting people lead healthier lives.